Data / Drug companies / Clindamycin hydrochloride
Clindamycin hydrochloride: 34 companies and 92 products in the FDA NDC directory
Clindamycin hydrochloride is listed in the FDA National Drug Code Directory by 34 companies, with 92 products in commercial distribution. 89 of the products (96.7%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are capsule; capsule, gelatin coated, and the newest product started marketing on June 3, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 34
- Products
- 92
- Generic (ANDA) products
- 89 (96.7%)
- Application numbers
- 7
- Routes
- Oral
- Brand names
- Cleocin Hydrochloride
- openFDA record search
- api.fda.gov
Companies that list clindamycin hydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| NuCare Pharmaceuticals,Inc. | 13 | capsule | Generic drugs (ANDA) | March 10, 2023 |
| A-S Medication Solutions | 11 | capsule | Generic drugs (ANDA) | March 10, 2023 |
| Bryant Ranch Prepack | 7 | capsule | Generic drugs (ANDA) | March 10, 2023 |
| Asclemed USA, Inc. | 4 | capsule | Generic drugs (ANDA) | January 7, 2019 |
| Remedyrepack Inc. | 4 | capsule | Generic drugs (ANDA) | March 9, 2026 |
| Chartwell RX, LLC | 3 | capsule | Generic drugs (ANDA) | August 12, 2005 |
| Glenmark Pharmaceuticals Inc., USA | 3 | capsule | Generic drugs (ANDA) | March 10, 2023 |
| Micro Labs Limited | 3 | capsule | Generic drugs (ANDA) | January 7, 2019 |
| Northwind Health Company, LLC | 3 | capsule | Generic drugs (ANDA) | March 13, 2023 |
| PD-Rx Pharmaceuticals, Inc. | 3 | capsule | Generic drugs (ANDA) | January 7, 2019 |
| Pharmacia & Upjohn Company LLC | 3 | capsule | New drug applications (NDA) | May 22, 1970 |
| Proficient Rx LP | 3 | capsule | Generic drugs (ANDA) | August 26, 2009 |
| Redpharm Drug | 3 | capsule | Generic drugs (ANDA) | March 10, 2023 |
| St. Mary's Medical Park Pharmacy | 3 | capsule | Generic drugs (ANDA) | July 30, 2024 |
| American Health Packaging | 2 | capsule | Generic drugs (ANDA) | May 2, 2008 |
| Aurobindo Pharma Limited | 2 | capsule | Generic drugs (ANDA) | August 26, 2009 |
| Hawaii Repack, Inc. | 2 | capsule | Generic drugs (ANDA) | March 23, 2001 |
| Major Pharmaceuticals | 2 | capsule | Generic drugs (ANDA) | August 26, 2009 |
| Preferred Pharmaceuticals Inc. | 2 | capsule | Generic drugs (ANDA) | June 1, 2024 |
| Sun Pharmaceutical Industries, Inc. | 2 | capsule | Generic drugs (ANDA) | March 23, 2001 |
| Advanced Rx of Tennessee, LLC | 1 | capsule | Generic drugs (ANDA) | July 16, 2024 |
| Amneal Pharmaceuticals NY LLC | 1 | capsule, gelatin coated | Generic drugs (ANDA) | April 25, 2022 |
| AvPAK | 1 | capsule | Generic drugs (ANDA) | October 27, 2020 |
| Brisk Pharmaceuticals | 1 | capsule | Generic drugs (ANDA) | March 10, 2023 |
| Cardinal Health 107, LLC | 1 | capsule | Generic drugs (ANDA) | April 10, 2009 |
| Coupler LLC | 1 | capsule | Generic drugs (ANDA) | April 29, 2026 |
| Direct_Rx | 1 | capsule | Generic drugs (ANDA) | June 4, 2021 |
| Golden State Medical Supply, Inc. | 1 | capsule | Generic drugs (ANDA) | February 2, 2001 |
| Proficient Rx LP | 1 | capsule | Generic drugs (ANDA) | January 7, 2019 |
| Proficient Rx LP | 1 | capsule | Generic drugs (ANDA) | March 10, 2023 |
| Quality Care Products, LLC | 1 | capsule | Generic drugs (ANDA) | June 7, 2019 |
| Sportpharm LLC | 1 | capsule | Generic drugs (ANDA) | March 10, 2023 |
| Unit Dose Solutions, Inc. | 1 | capsule | Generic drugs (ANDA) | June 3, 2026 |
| Verityrx, LLC | 1 | capsule | Generic drugs (ANDA) | August 26, 2009 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule | 91 | 98.9% |
| Capsule, gelatin coated | 1 | 1.1% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 89 | 96.7% |
| New drug applications (NDA) | 3 | 3.3% |
Pharmacologic classes
| Class | Products |
|---|---|
| Lincosamide Antibacterial | 92 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.